Posted by Michael Wonder on 08 May 2017
Many New Zealanders to benefit from latest PHARMAC funding proposals
7 May 2017 - A series of 38 funding proposals across the breadth and scope of PHARMAC’s work has been released for public feedback.
The proposals range from new technology for patients with high health needs, to everyday solutions that would benefit families across New Zealand. These proposals would mean new fully-funded treatments being available from 1 July 2017.
PHARMAC’s work is about ensuring all New Zealanders get access to a wide range of useful and best value treatments.
“PHARMAC is constantly looking across all medicines to see if more people could benefit from new treatments and from those already funded,” says Chief Executive Steffan Crausaz. “We’re pleased that as a result of our work more than 30,000 New Zealanders would have the chance to live longer, healthier lives, while families would experience positive benefits with new medicines for children.”
